Cargando…

Voriconazole-Induced Periostitis Mimicking Chronic Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation

Voriconazole is an established first-line agent for treatment of invasive fungal infections in patients undergoing allogeneic stem cell transplantation (ASCT). It is associated with the uncommon complication of periostitis. We report this complication in a 58-year-old female undergoing HSCT. She was...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sweiss, Karen, Oh, Annie, Rondelli, Damiano, Patel, Pritesh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4923522/ https://www.ncbi.nlm.nih.gov/pubmed/27403356 http://dx.doi.org/10.1155/2016/3242196

Ejemplares similares

Blockade of TNFα to Improve Human CD34+ Cell Repopulating Activity in Allogeneic Stem Cell Transplantation
por: Senyuk, Vitalyi, et al.
Publicado: (2019)

Voriconazole-induced periostitis post lung transplantation
por: Murray, Orla M., et al.
Publicado: (2022)

Improved health care utilization and costs in transplanted versus non-transplanted adults with sickle cell disease
por: Saraf, Santosh L., et al.
Publicado: (2020)

Voriconazole-Induced Diffuse Periostitis
por: Stefan, Simona, et al.
Publicado: (2022)

Thoracic periosteal reaction secondary to voriconazole use in an adult transplant patient
por: Shetty, Anisha N., et al.
Publicado: (2023)

Voriconazole-Induced Periostitis: A Case Report
por: Cooper-Roth, Tristan D, et al.
Publicado: (2023)

Voriconazole-Induced Periostitis & Enthesopathy in Solid Organ Transplant Patients: Case Reports
por: Sircar, Monica, et al.
Publicado: (2016)

Voriconazole‐Associated Periostitis: New Insights into Pathophysiology and Management
por: Bennett, Michael J, et al.
Publicado: (2021)

Allogeneic Hematopoietic Stem Cell Transplantation for Adults with Sickle Cell Disease
por: Saraf, Santosh L., et al.
Publicado: (2019)

Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation
por: Marks, David I, et al.
Publicado: (2011)

Hyperacute Graft-Versus-Host Disease Mimicking Stevens-Johnson Syndrome in a Patient With Allogeneic Hematopoietic Stem Cell Transplantation
por: Bostan, Ecem, et al.
Publicado: (2022)

Graft-versus-host disease in allogeneic transplantation: the good and the bad
por: Kröger, Nicolaus-Martin
Publicado: (2022)

Impact of Inflammatory Cytokine Gene Polymorphisms on Developing Acute Graft-versus-Host Disease in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
por: Masetti, Riccardo, et al.
Publicado: (2015)

Haploidentical Peripheral Blood Stem Cell Transplantation Demonstrates Stable Engraftment in Adults with Sickle Cell Disease
por: Saraf, Santosh L., et al.
Publicado: (2018)

Giardia lamblia mimicking acute graft versus host disease after allogeneic hematopoietic stem cell transplantation: A case report
por: Ma, Shengling, et al.
Publicado: (2020)

Allogeneic hematopoietic cell transplantation, the microbiome, and graft-versus-host disease
por: van Lier, Yannouck F., et al.
Publicado: (2023)

Interleukin-22 in Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation
por: Lamarthée, Baptiste, et al.
Publicado: (2016)

Purinergic Signalling in Allogeneic Haematopoietic Stem Cell Transplantation and Graft-versus-Host Disease
por: Cuthbertson, Peter, et al.
Publicado: (2021)

Voriconazole-associated periostitis: Pathophysiology, risk factors, clinical manifestations, diagnosis, and management
por: Guarascio, Anthony J, et al.
Publicado: (2021)

The Role of Pattern-Recognition Receptors in Graft-Versus-Host Disease and Graft-Versus-Leukemia after Allogeneic Stem Cell Transplantation
por: Heidegger, Simon, et al.
Publicado: (2014)

Methotrexate for the Treatment of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
por: Nassar, Amr, et al.
Publicado: (2014)

Antibiotic Therapy and Gastrointestinal Graft-Versus-Host Disease in the Allogeneic Stem Cell Transplantation Population
por: Thomas, Jessica, et al.
Publicado: (2022)

Preclinical IV busulfan dose-finding study to induce reversible myeloablation in a non-human primate model
por: Mahmud, Nadim, et al.
Publicado: (2018)

Muscle Cramps and Neuropathies in Patients with Allogeneic Hematopoietic Stem Cell Transplantation and Graft-versus-Host Disease
por: Kraus, Peter D., et al.
Publicado: (2012)

Myasthenia Gravis Presenting as Graft versus Host Disease after Allogeneic Blood Stem Cell Transplant
por: Ahmed, Zarir, et al.
Publicado: (2018)

Demodicidosis Accompanying Acute Cutaneous Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation
por: Aytan, Pelin, et al.
Publicado: (2018)

Helper Innate Lymphoid Cells in Allogenic Hematopoietic Stem Cell Transplantation and Graft Versus Host Disease
por: Quatrini, Linda, et al.
Publicado: (2020)

Dermoscopy of Cutaneous Graft-Versus-Host-Disease in Patients After Allogeneic Hematopoietic Stem Cell Transplantation
por: Kaminska-Winciorek, Grażyna, et al.
Publicado: (2020)

Acute Graft-Versus-Host Disease of the Kidney in Allogeneic Rat Bone Marrow Transplantation
por: Higo, Seiichiro, et al.
Publicado: (2014)

Gastric and small bowel perforations secondary to mucormycosis and graft versus host disease in an allogeneic transplant host
por: Ibrahim, Uroosa, et al.
Publicado: (2021)

Histoplasma capsulatum Infection in an Allogeneic Hematopoietic Stem Cell Transplant Patient Receiving Voriconazole Prophylaxis
por: Agrawal, Vaibhav, et al.
Publicado: (2020)

Cytokines in tear fluid of patients with ocular graft-versus-host disease after allogeneic stem cell transplantation
por: Riemens, Anjo, et al.
Publicado: (2012)

Etanercept for steroid-refractory acute graft versus host disease following allogeneic hematopoietic stem cell transplantation
por: Park, Joo Han, et al.
Publicado: (2014)

More immune dysregulation: Sarcoidosis and chronic graft-versus-host disease after allogeneic stem cell transplant
por: Manalo, Iviensan F., et al.
Publicado: (2016)

Extracoporeal photopheresis treatment of acute graft-versus-host disease following allogeneic haematopoietic stem cell transplantation
por: Flinn, Aisling M., et al.
Publicado: (2016)

Invariant Natural Killer T Cells As Suppressors of Graft-versus-Host Disease in Allogeneic Hematopoietic Stem Cell Transplantation
por: Mavers, Melissa, et al.
Publicado: (2017)

Characteristics and risk of chronic graft-versus-host disease of liver in allogeneic hematopoietic stem cell transplant recipients
por: Chen, Chien-Ting, et al.
Publicado: (2017)

The role of serum uric acid in the prediction of graft‐versus‐host disease in allogeneic hematopoietic stem cell transplantation
por: Ghasemi, Katayoon, et al.
Publicado: (2020)

Central Nervous System-related Graft-versus-host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
por: Kaito, Yuta, et al.
Publicado: (2021)

Effect of Early Post-Transplantation Tacrolimus Concentration on the Risk of Acute Graft-Versus-Host Disease in Allogenic Stem Cell Transplantation
por: Sharma, Nidhi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kc8nhnf6d0648iakeatjq4jat2